First, to further support the microarray data expression levels in a bigger sample size, we performed in silico analyses taking advantage of established datasets of GBM IDH wild-type, such as ‘The Cancer Genome Atlas’ (TCGA) and ‘Gravendeel’ cohorts. The gene discussed is IDH2; the disease is glioblastoma.